Ashland Inc. (ASH)
NYQ – Real Time Price. Currency in USD
56.72
+2.64 (4.88%)
At close: May 12, 2026, 4:00 PM EDT
Find any stock by ticker or company name

NYQ – Real Time Price. Currency in USD
56.72
+2.64 (4.88%)
At close: May 12, 2026, 4:00 PM EDT
Ashland Inc. provides additives and specialty ingredients in the North and Latin America, Europe, Asia Pacific, and internationally. It operates through Life Sciences, Personal Care, Specialty Additives, and Intermediates segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; and nutrition solutions, such as thickeners, stabilizers, emulsifiers, and additives; agricultural chemicals; diagnostic films; and fine chemicals. Its Personal Care segment provides a range of natural, nature-derived, biodegradable, and performance ingredients; solutions for toothpastes, mouth washes and rinses, denture cleaning, and care for teeth; and household supplies nature-derived rheology ingredients, biodegradable surface wetting agents, performance encapsulates, and specialty polymers. The Specialty Additives segment offers rheology modifiers, foam control agents, surfactants and wetting agents, pH neutralizers, advanced ceramics used in catalytic converters, environmental filters, ingredients for the manufacturing of ceramic capacitors, plasma display panels and solar cells, ingredients for textile printing, thermoplastic metals, and alloys for welding. Its Intermediates segment produces 1,4 butanediol and related derivatives, including n-methylpyrrolidone. It offers its products to customers in a range of consumer and industrial markets, such as architectural coatings, construction, energy, food and beverage, personal care, and pharmaceutical. The company was formerly known as Ashland Global Holdings Inc. and changed its name to Ashland Inc. in August 2022. Ashland Inc. was founded in 1924 and is headquartered in Wilmington, Delaware.
| Name | Position |
|---|---|
| Carolmarie C. Brown | Vice President of Corporate Affairs, Global Marketing, Brand & Business Communications |
| Dr. Osama M. Musa Ph.D. | Senior VP & CTO |
| Mr. Guillermo Novo | Chairman & CEO |
| Mr. James P. Minicucci | Senior VP & GM of Personal Care |
| Mr. Samuel A. Richardson | VP, Controller & Principal Accounting Officer |
| Mr. Wayne Muil | Senior Vice President of Operations |
| Mr. William C. Whitaker C.F.A. | Senior VP, CFO & Director of Investor Relations |
| Ms. Alessandra Faccin Assis | Senior VP and GM of Life Sciences & Intermediates |
| Ms. Eileen M. Drury | Senior VP & Chief HR Officer |
| Ms. Robin E. Lampkin | Senior VP, General Counsel & Secretary |
| Date | Type | Document |
|---|---|---|
| 2026-04-29 | 10-Q | ash-20260331.htm |
| 2026-04-28 | 8-K | ash-20260428.htm |
| 2026-02-03 | 10-Q | ash-20251231.htm |
| 2026-02-02 | 8-K | ash-20260202.htm |
| 2026-01-27 | 8-K | ash-20260126.htm |
| 2026-01-22 | 8-K | ash-20260120.htm |
| 2025-12-09 | DEF 14A | ash-20251209.htm |
| 2025-11-20 | 10-K | ash-20250930.htm |
| 2025-11-04 | 8-K | ash-20251104.htm |
| 2025-09-18 | 8-K | ash-20250916.htm |